Intracerebral Administration of Autologous Mesenchymal Stem Cells as HSV-TK Gene Vehicle for Treatment of Glioblastoma Multiform: Safety and Feasibility Assessment

The safety and feasibility of using bone marrow–derived MSCs in combination with prodrug for treatment of patients with primary and secondary glioblastoma multiform was assessed.